Coronary disease & ACS

International study of coronary microvascular angina (iCorMicA): A registry-based diagnostic study and nested randomized trial

Am Heart JPublished international, multicenter, prospective, registry-based study and nested, randomized, controlled, triple-blind, and endpoint trial

Study context

Population
Patients with angina undergoing invasive management (coronary angiography); participants without obstructive coronary artery disease eligible for randomizationenrolled into the registry · randomized 1,047 · not randomized (registry-only) 386
Participants
1,483 patients
Planned comparison
Coronary function test-guided management vs results not disclosed
Primary endpoint
Within-individual change in Seattle Angina Questionnaire summary score (randomized trial)
Follow-up
12-months from baseline
Methodological detailsParticipants, community care providers, and outcomes assessors are masked
  • Participants, community care providers, and outcomes assessors are masked

No results yet. This paper sets out the design of a trial; its results are to come.

Further findings

Study conduct

First patient screened
December 18, 2020
Last patient enrolled
June 30, 2026
Sites
Forty
United Kingdom
n = 35
Republic of Ireland
n = 2
Holland
n = 2
Poland
n = 1

Original publication

International study of coronary microvascular angina (iCorMicA): A registry-based diagnostic study and nested randomized trial. Am Heart J. Published 6 July 2026. doi:10.1016/j.ahj.2026.107527

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.